Ethylenediaminetetraacetic acid (EDTA) is a medication used in the management and treatment of heavy metal toxicity. It is in the chelating class of drugs. This activity outlines and reviews the indications, actions, and contraindications for EDTA as a valuable agent in managing lead toxicity. This activity will highlight the mechanism of action, side effect profile, and other key factors such as dosing, pharmacokinetics, and monitoring pertinent for members of the healthcare team in the use of EDTA.

**Objectives:**
- Outline the indications for EDTA.
- Identify the most common adverse effects associated with EDTA therapy.
- Explain the importance of monitoring for patients on EDTA therapy, including renal function tests.
- Identify the mechanism of action of EDTA.